Topical psoriasis therapy

Daniel G. Federman, Catherine W. Froelich, Robert S. Kirsner

Research output: Contribution to journalArticle

21 Scopus citations


Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis.

Original languageEnglish (US)
Pages (from-to)957-962
Number of pages6
JournalAmerican Family Physician
Issue number4
StatePublished - Feb 15 1999

ASJC Scopus subject areas

  • Family Practice

Fingerprint Dive into the research topics of 'Topical psoriasis therapy'. Together they form a unique fingerprint.

  • Cite this

    Federman, D. G., Froelich, C. W., & Kirsner, R. S. (1999). Topical psoriasis therapy. American Family Physician, 59(4), 957-962.